glp1
Best Semaglutide Provider in 2026: How to Compare Telehealth Platforms Before You Spend $300 a Month
June 3, 2026
You've done two or three hours of research, you have five browser tabs open comparing telehealth platforms, and you still can't tell whether you're about to pay $400 a month for the same compounded semaglutide or something meaningfully different. That's the actual state of shopping for semaglutide in mid-2026 — a market crowded enough that the real differentiators are buried under identical landing pages and vague "medically supervised" promises.
Here's what actually separates the providers worth using from the ones worth skipping.
The Compounded vs. Brand-Name Question Is Still Live
The FDA's back-and-forth on compounded semaglutide availability defined most of 2025. By early 2026, branded Wegovy (semaglutide 2.4 mg/week) is broadly available again, and most telehealth platforms have pivoted to offering both tracks — compounded at a lower price point, brand-name for patients who can access insurance coverage or prefer the regulated supply chain.
That distinction matters for choosing a provider. Platforms that only offer compounded product give you fewer options if your insurance situation changes. Platforms that only carry brand-name typically mean paying Wegovy's list price of around $1,349 per month without coverage, though most patients with commercial insurance pay a $25–$99 copay under manufacturer savings programs. The best online GLP-1 programs right now are the ones that let you start on compounded, then transition to brand-name if coverage kicks in — without switching platforms.
What Compounded Semaglutide Actually Costs in 2026
The range is wide. Entry-level telehealth programs advertise compounded semaglutide injections for as low as $149/month, but that's typically the 0.25 mg starter dose with no titration support built into the price. Full-protocol programs — where the monthly cost covers dose titration through 1 mg or higher, provider check-ins, and metabolic labs — run $250–$399/month depending on the platform.
Comparing on price alone requires factoring in what's included. Some platforms charge separately for the initial consultation ($75–$150 one-time) and for labs. Others bundle everything. A platform showing $179/month but charging $125 for intake and $90 for required bloodwork costs more in year one than a $299/month all-in program.
For a detailed breakdown of how programs structure costs, the compare GLP-1 providers page breaks this down across the major platforms including consultation fees, included labs, and whether supply is sent monthly or in bulk.
The Platforms Worth Knowing
Eden Health is one of the more straightforward options for patients who want compounded semaglutide quickly. Their intake process is asynchronous — you fill out a medical form, a provider reviews it, and product ships within a few business days if you're approved. Monthly pricing for compounded semaglutide starts around $196. Eden Health operates in most US states and has a relatively clean record on supply consistency, which matters given how often compounders have faced quality control issues.
Shed (formerly ShedRx) is the platform to consider if you're needle-averse. They offer compounded semaglutide and tirzepatide in both injectable and sublingual lozenge form — which is unusual in this market. The lozenge route has lower bioavailability than subcutaneous injection, but for patients who can't tolerate needles, it's a real option rather than a workaround. Shed also backs their program with a 10% weight-loss-or-money-back guarantee, which is the only outcome-based guarantee of its kind currently offered by a major telehealth GLP-1 platform. They also carry FDA-approved Wegovy and Zepbound for patients who qualify.
Trim Rx and Yucca Health are the platforms to compare if you want more structured clinical oversight. Trim Rx includes dietitian access in their program pricing. Yucca Health has built a longitudinal care model suited to patients who want ongoing metabolic management rather than a defined weight-loss timeline.
For a direct side-by-side, the Eden vs Shed comparison covers pricing structure, shipping timelines, and what each platform does (and doesn't) include in their standard program.
What the Clinical Evidence Actually Shows
The STEP 1 trial (Wilding et al., 2021, N=1,961) established semaglutide 2.4 mg at 14.9% mean body weight reduction over 68 weeks — the headline number most providers are implicitly selling against. That number omits two things: roughly 13% of participants discontinued due to adverse events, mostly GI-related, and weight regain after stopping the drug is well-documented in follow-up data. A good provider discusses both with you proactively rather than leaving them in the fine print.
The practical implication: a provider that prescribes and ships without any discussion of dose titration protocol, GI management, or pause procedures is doing logistics, not clinical oversight. The titration schedule matters because most GI side effects occur at dose increases. Standard protocol moves from 0.25 mg/week to 0.5 mg at week 4, then 1 mg at week 8, with further increases based on response and tolerance. Platforms that auto-titrate on a fixed schedule without checking in produce higher dropout rates — and the STEP 1 discontinuation rate shows that's a real cost, not a theoretical one.
The Questions to Ask Before You Sign Up
Four questions that filter out the low-effort providers quickly:
- Who reviews my intake? A licensed physician or NP reviewing your case is different from an algorithm flagging contraindications. Ask explicitly.
- What's included if I need a dose adjustment? Some platforms charge for additional provider contacts. Others include it.
- How do you handle supply disruption? With compounders, this is still a live issue. What's the plan if your batch is delayed?
- What lab work do you require, and when? Baseline metabolic panel and HbA1c are standard; ongoing monitoring should happen at least every 90 days.
The Actual Bottom Line
The best semaglutide provider for most patients isn't the cheapest or the one with the fastest shipping — it's the one whose clinical model matches your situation. If you're needle-averse, Shed's sublingual lozenge changes the calculus. If you want minimal friction and fast onboarding, Eden's asynchronous intake at $196/month is competitive. If you want dietitian support built into the program price, Trim Rx is worth the higher monthly cost. If your insurance landscape might change, pick a platform that carries both compounded and brand-name options — Eden and Shed both do — rather than one that forces you to restart somewhere else when Wegovy coverage kicks in.
The market has matured enough that you can hold providers to a higher standard. Use that.
Peptide Clinic Finder is a comparison platform. The author may receive compensation if you sign up through links on our partner pages.